Older people with vision loss are significantly more likely to suffer mild cognitive impairment, which can be a precursor to dementia, according to a new study published in the journal Ageing Clinical and Experimental Research.
Ten remarkable women who are Wills Eye Hospital faculty physicians and Wills Eye alumnae have been named to the Inaugural all-women Power List, published by The Ophthalmologist.
Residents of some NYC public housing developments can get free vision screening and eye exams in their building, as part of a new study led by Columbia University’s Department of Ophthalmology.
The magical ultraviolet C (UVC) sterilizing devices are proven to kill 99.99% of germs, but may pose a risk of skin cancer and cataracts, Chula professors cautioned consumers to use them carefully and by being fully informed.
As regenerative therapies for blinding diseases move closer to clinical trials, the National Eye Institute’s functional imaging consortium, a part of the NEI Audacious Goals Initiative (AGI), is pioneering noninvasive technologies to monitor the function of the retina’s light-sensing neurons and their connections to the brain.
New advances by medical researchers and engineers at the University of Wisconsin–Madison may provide hope for those suffering from vision loss.
As kids begin to resume their favorite sports, the American Academy of Ophthalmology is reminding the public that the best defense against potentially blinding sports-related injuries is wearing protective eyewear.
A new gene therapy for one of the most common forms of congenital blindness was safe and improved patients’ vision, according to initial data from a clinical trial.
A Penn Medicine patient with a genetic form of childhood blindness gained vision, which lasted more than a year, after receiving a single injection of an experimental RNA therapy into the eye.
The national Ocular Hypertension Treatment Study was designed to determine whether lowering elevated eye pressure in patients might prevent vision loss from glaucoma. Researchers recently completed follow-up studies on patients 20 years after the start of the original study and found that not all patients with elevated eye pressure need pressure-lowering treatment to prevent vision loss from glaucoma.
Just as humans are challenged from the social isolation caused by the coronavirus pandemic, a new study finds that a solitary lifestyle has profound effects on the brains of a social insect: paper wasps.
Research to Prevent Blindness and The Glaucoma Foundation are pleased to announce a new round of grants, the Career Advancement Awards (CAAs), that support early-career researchers as they seek new knowledge related to eye diseases.
Smoking cannabis significantly impairs vision but many users are unaware of it
NIH supported early testing of the artificial retina. Now, scientists are testing whether manufacturing it on the International Space Station results in a viable treatment for people with blinding eye diseases.
Using laboratory-grown roundworms as well as human and mouse eye tissue, University of Maryland School of Medicine (UMSOM) researchers have identified a new potential mechanism for age-related macular degeneration—the leading cause of blindness among older adults.
Michael S. Gilmore, PhD, a renowned microbiologist who has led infectious disease efforts at leading research institutions, has been appointed the first Chief Scientific Officer at Mass Eye and Ear, a member hospital of Mass General Brigham, following an extensive search.
Human brains can do more than simply imagine the presence of nonexistent objects. Our minds can automatically create well-defined representations of objects that are merely implied rather than seen, like the obstacles in a mime’s performance. These findings could aid in the development of artificial intelligence related to vision and navigation by helping understand how humans perceive and navigate their environments.
People who consume alcohol moderately appear less likely to develop cataracts that require surgery. The new research was published as an Article In Press in Ophthalmology, the journal of the American Academy of Ophthalmology.
Early treatment with anti-VEGF injections slowed diabetic retinopathy in a clinical study from the DRCR Retina Network (DRCR.net). However, two years into the four-year study its effect on vision was similar to standard treatment, which usually begins at the onset of late disease.
The discovery of a new gene linked to eye disorders of cataract and small or reduced eye tissue at the University of Delaware has earned a four-year grant to support further work exploring the role of the gene, Elav11 and its partners in eye development.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right